Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 5Phase 4 4Phase 1 3Phase NA 1

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 33INDUSTRY 5UNKNOWN 1NETWORK 1

Study Type

Interventional 5

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 685Breast Neoplasms 584Neoplasms 468Colorectal Neoplasms 298Prostatic Neoplasms 262Neoplasm Metastasis 256Melanoma 241Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 195Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 141Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Head and Neck Neoplasms 112Squamous Cell Carcinoma of Head and Neck 111Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Small Cell Lung Carcinoma 95Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 76Triple Negative Breast Neoplasms 72

Interventions

Ondansetron 2Aprepitant 2casopitant 1Palonosetron 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Nausea × Clear all
NCT07169851 2026-04-22

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Eli Lilly and Company

Phase 2 Recruiting
204 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT06904235 2026-03-31

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Helsinn Healthcare SA

Phase 2 Recruiting
95 enrolled

Nausea, Vomiting

NCT00285051 2020-12-23

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Rafa Laboratories

Phase 2 Terminated
6 enrolled

Nausea, Neoplasms, Vomiting

NCT00212602 2012-06-14

ONO-7436 Phase II Study in Japan

Ono Pharmaceutical Co., Ltd.

Phase 2 Completed
420 enrolled

Nausea, Neoplasms, Vomiting

NCT00169572 2010-05-10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

GlaxoSmithKline

Phase 2 Completed
492 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡